M&K CPAS confirms Virtuix auditor change
Virtuix appointed M&K CPAS as its new auditor, prompting the firm to confirm financial statements in an SEC 8-K letter.
View filing at SEC.gov →9 most recent filings and news items mentioning VRTX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/VRTX/news?limit=20"
Pull VRTX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayVirtuix appointed M&K CPAS as its new auditor, prompting the firm to confirm financial statements in an SEC 8-K letter.
View filing at SEC.gov →Vertex Pharmaceuticals agreed to acquire Crinetics for $85 per share. Net product revenue for the quarter was $24.0 million.
View filing at SEC.gov →Nasdaq Jumps 1% as Amazon Shares Surge: Investor Sentiment Improves, But Greed Index Remains in 'Fear' Zone
View filing at SEC.gov →AbCellera collaborated with Vertex Pharmaceuticals to develop multispecific T-cell engagers, receiving $28.1 million in upfront payments. The deal strengthens AbCellera's position in the advanced autoimmune and immunology markets.
View filing at SEC.gov →Vertex Pharmaceuticals announced plans to acquire Crinetics Pharmaceuticals to bolster its pipeline and revenue projections. The deal is fully funded by committed bridge financing and is expected to contribute to significant growth and accretion by 2029.
View filing at SEC.gov →Virtuix Holdings amended a warrant to lower the exercise price to $3.00 per share during a defined period. This adjustment aims to incentivize investors to exercise their warrants and is effective upon the filing of a registration statement update.
View filing at SEC.gov →IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’
View filing at SEC.gov →CNBC Halftime Report Final Trades: Corning, IBM, Vertex Pharmaceuticals, Verizon Communications
View filing at SEC.gov →Virtuix Holdings amended its equity financing warrant with Streeterville Capital, reducing the exercise price to $4.00 per share through June 1, 2026, with the company retaining termination rights. The amendment reflects ongoing capital structure adjustments for the VR technology
View filing at SEC.gov →